Diabetic foot ulcers are not a minor complication. They represent one of the most devastating and costly consequences of diabetes mellitus in the U.S.
- Approximately 15% of all diabetic patients will develop a foot ulcer during their lifetime.
- DFUs account for 40% to 60% of all non-traumatic lower limb amputations in the United States.
- The International Diabetes Federation projects that more than 853 to 1.3 billion people globally will have diabetes by 2050, intensifying the DFU burden.
From the above facts, we can comprehend that the U.S. ranks above the national average for diabetes prevalence. Improving wound care access and getting accurate HBOT reimbursement is vital for providers and patients in Kansas and all over the U.S. This guide gives you every fact you need so you can make a confident, informed decision about your health.
What Is Hyperbaric Oxygen Therapy (HBOT)?
Hyperbaric oxygen therapy is a medical treatment in which a patient breathes 100% pure oxygen inside a pressurized chamber. The chamber operates at 1.9 to 3.0 atmospheres absolute (ATA), roughly two to three times normal atmospheric pressure. Under these conditions, oxygen dissolves directly into blood plasma, tissue fluid, and lymph at concentrations far exceeding what normal breathing achieves.
How HBOT Works at the Cellular Level
Diabetic foot ulcers (DFUs) fail to heal primarily because of tissue hypoxia, a chronic oxygen deficit caused by peripheral vascular disease, neuropathy, and impaired microcirculation. HBOT directly counteracts this by:
- Stimulating angiogenesis: the growth of new blood vessels into ischemic tissue
- Enhancing collagen synthesis: the structural protein essential to wound closure
- Amplifying white blood cell function: improving the body’s ability to fight biofilm and deep infection
- Reducing inflammatory cytokines: calming the chronic inflammatory cycle that stalls healing
- Improving fibroblast proliferation: accelerating the rebuilding of damaged tissue
Does HBOT Actually Work for Diabetic Foot Ulcers?
This is the core question and the answer we found in one of the research data sets, which is clear.
2025 Systematic Review (Cureus / PMC)
A systematic review published in February 2025 analyzed six studies involving 391 patients. The majority of studies indicated:
- Reduced major amputation rates with HBOT versus standard care alone
- Improved ulcer healing rates
- Decreased ulcer size and depth
The standard HBOT protocol across included studies: 20 to 40 sessions, each lasting 60 to 120 minutes at pressures of 2.0 to 2.5 ATA, conducted 5 to 6 days per week.
CMS and Medicare Coverage for HBOT in Kansas
For Kansas providers and patients, understanding the exact Medicare coverage criteria is essential, both for patient access and for clean claims.
Medicare National Coverage Determination (NCD 20.29)
The Centers for Medicare & Medicaid Services (CMS) has issued a positive National Coverage Determination for HBOT specifically for diabetic foot ulcers.
To qualify for Medicare coverage, all of the following must be documented:
- Patient has Type 1 or Type 2 diabetes with a lower extremity wound caused by diabetes
- The wound is classified as Wagner Grade III or higher
- The wound has shown no measurable signs of healing for at least 30 consecutive days of standard wound therapy
- HBOT is used adjunctively alongside, not instead of standard wound care
- The wound must be evaluated at least every 30 days during the HBOT course, with documented evidence of measurable healing progress.
Not covered under NCD 20.29: cutaneous ulcers, decubitus ulcers, stasis ulcers, or wounds that are surgical complications of diabetes.
What Standard Wound Care Must Include Before HBOT
Before Kansas providers can initiate HBOT and bill Medicare, documentation must show that standard care was provided and failed. Per Noridian (the Medicare Administrative Contractor for Kansas), standard diabetic wound care documentation must include:
- Vascular status assessment and correction, where applicable
- Infection control and management
- Maintenance of a clean, moist wound bed with appropriate dressings
- Glycemic control measures
- Pressure offloading
Cost and Medicare Reimbursement
Under Medicare Part B, patients typically pay 20% of the approved amount after their annual deductible. Supplemental insurance may cover the remaining balance.
HBOT Billing and Coding — Critical Details for Kansas Providers
Errors in HBOT billing are a significant source of claim denials and compliance risk. Here is what every Kansas wound care provider must know.
Key CPT and HCPCS Codes
- CPT 99183: Physician supervision of HBOT (non-outpatient setting)
- HPCS C1300: Physician supervision (outpatient setting)
- HCPCS G0277: HBOT treatment, billed in 30-minute increments
- ICD-10-CM E11.621: Type 2 diabetes with foot ulcer (example; code must match patient specifics)
Medically Unlikely Edits (MUEs)
Medicare MUEs limit daily HBOT billing to five 30-minute units. If extended treatment is medically necessary, detailed documentation is required for successful appeals.
Documentation Checklist to Avoid Denials
Claim denials for HBOT are frequently tied to missing documentation. Kansas providers should ensure every HBOT claim file contains:
- Diabetes diagnosis (Type 1 or 2) confirmed
- Wagner Grade assignment documented by the treating provider
- Wound measurement records showing no healing for 30+ consecutive days on standard care
- Documentation that HBOT is adjunctive to not replacing standard wound care
- Monthly wound evaluation notes during the HBOT course showing healing progress (or medical justification for continuation if progress is minimal)
- Vascular status assessment on record
- Physician supervision confirmed per session
The Targeted Probe and Educate (TPE) audit initiative by CMS has specifically targeted HBOT claims. Missing documentation requirement is the most common reason providers face post-payment audits and recoupments.
What HBOT Treatment Protocol Can Patients in Kansas Expect
Patients enter either a monoplace chamber (single-person, acrylic tube) or a multiplace chamber (larger room accommodating multiple patients). They breathe 100% oxygen through a mask or hood while chamber pressure is gradually increased.
Each session typically lasts 60 to 120 minutes. Most patients report mild ear pressure similar to airplane descent, a manageable side effect that usually resolves quickly.
Transcutaneous Oxygen Pressure (TcPO2) Testing
Before and during HBOT, many wound care centers use TcPO2 testing, measuring oxygen levels in the tissue surrounding the wound. Research by Fife et al. (reviewed in CMS NCD documentation) found that TcPO2 measurements taken while breathing oxygen under hyperbaric conditions predicted a positive outcome in 74% of patients, with a threshold of 200 mmHg most associated with favorable results. This test helps identify which patients are likely to respond to HBOT, reducing unnecessary treatment exposure.
Risks, Contraindications, and Safety Considerations
HBOT has an established safety profile when administered by trained hyperbaric medicine specialists, but risks exist.
Common Side Effects
Barotraumatic otitis (ear pressure/pain)
The most frequently reported adverse event rarely requires myringotomy tubes.
Temporary visual changes
They are typically reversible myopia that resolves after treatment ends.
Claustrophobia
It is reported in less number of patients in most studies.
Serious Risks (Rare)
- Oxygen toxicity seizures (rare with proper protocols)
- Fire hazard in high-oxygen environments — reputable facilities follow strict safety protocols
- Cardiac arrhythmia (reported rarely in older literature)
Absolute Contraindications
- Untreated pneumothorax, the only absolute contraindication recognized universally
- Concurrent use of certain chemotherapy agents (e.g., doxorubicin, bleomycin)
- Uncontrolled high fever
Relative contraindications requiring physician evaluation include COPD with CO2 retention, active ear or sinus infections, and a history of seizure disorders.
Kansas-Specific Considerations for Wound Care Providers
Kansas providers navigating HBOT billing operate under Noridian Healthcare Solutions as the Medicare Administrative Contractor (MAC) for both Part A and Part B services. Noridian has published specific LCD (Local Coverage Determination) guidance aligned with NCD 20.29 that Kansas providers must follow.
Key Kansas-specific billing points:
- All HBOT must be administered in a CMS-compliant hyperbaric chamber; Medicare does not cover home chamber use
- ICD-10-CM coding must precisely reflect the wound type and diabetic condition; undercoding or overcoding creates compliance exposure
Conclusion
Hyperbaric oxygen therapy is not a miracle cure. Still, for Kansas patients with severe diabetic foot ulcers, particularly Wagner Grade III and above, it is a clinically supported, Medicare-approved adjunctive treatment with meaningful evidence behind it.
For Kansas wound care providers, the single greatest risk to HBOT reimbursement is not clinical; it is documentation. Missing wound care failure record, failing to document monthly re-evaluations, or miscoding the Wagner grade are the most common pathways to denied claims, recoupments, and TPE audit exposure.
Getting the billing right protects your patients’ access to care and your practice’s financial health.
Kansas Medical Billing specializes in hyperbaric oxygen therapy billing, diabetic wound care coding, and Medicare compliance for Kansas providers. From accurate ICD-10-CM coding and HCPCS G0277 claims management to audit defense and documentation review, our team ensures your HBOT program gets reimbursed completely and compliantly.
Contact us today to schedule a free billing audit and discover how much revenue your wound care program may be leaving on the table.
Frequently Asked Questions About HBOT for Diabetic Foot Ulcers in Kansas
Does Medicare Part B cover HBOT for diabetic foot ulcers in Kansas?
Yes — if the wound is Wagner Grade III or higher, has not healed within 30 days of documented standard care, and the patient has Type 1 or Type 2 diabetes. Medicare Part B covers 80% of the approved cost after the annual deductible.
How do I know if my patient qualifies for HBOT?
The wound must meet Wagner Grade III criteria, demonstrate no measurable healing for 30 consecutive days on standard care, and the patient must have a confirmed diabetes diagnosis with a lower extremity wound attributable to diabetes. TcPO2 testing can further confirm physiologic candidacy.
What is the Wagner grading system?
Wagner grading classifies DFU severity from Grade 0 (pre-ulcerative lesion) to Grade 5 (gangrene of the entire foot). Medicare covers HBOT for Grade III and above — deep ulcers involving abscess, osteomyelitis, tendon/joint/capsule exposure, or gangrene.
Can HBOT prevent amputation?
Research supports a reduction in major amputation rates in patients with ischemic DFUs who complete their prescribed HBOT course. The 2021 Scientific Reports meta-analysis found a major amputation risk reduction of approximately 40% (RR = 0.60) compared to standard care alone. However, results vary by ulcer severity, vascular status, and patient adherence.
Can diabetics use hyperbaric oxygen therapy?
Our findings are consistent with those of previous studies showing that HBO improved fasting blood glucose levels in diabetes patients (31, 32) and ameliorated glucose tolerance (33).
